https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033698/
https://patents.justia.com/inventor/anthony-s-fauci
List of patents relative to GP120 owned by Fauci.
https://www.ncbi.nlm.nih.gov/pubmed/20088758
Reference that explains GP120
Has this been discussed? I understand the original study out of India which pointed this out experienced hard push back, but no one has yet provided a plausible explanation for how HIV glycoproteins naturally occurred in a coronavirus.
I posit that it is extremely unlikely to have naturally occurred within any timeline that makes sense, and is far more likely to have been inserted during a gain of function study.
Quote:
How the three bat CoV viruses obtain those inserts remains unknown. For any virus to obtain additional insert sequences from other organisms, it requires that it has direct interactions with other organisms, most likely through homologous or non-homologous recombination [11]. For bat CoV viruses to gain the gene fragments from HIV-1, it will require both viruses to co-infect the same cells. Because the host cells for bat CoV viruses and HIV-1 are different, the chance for both to exchange genetic materials is negligible
https://patents.justia.com/inventor/anthony-s-fauci
List of patents relative to GP120 owned by Fauci.
https://www.ncbi.nlm.nih.gov/pubmed/20088758
Reference that explains GP120
Has this been discussed? I understand the original study out of India which pointed this out experienced hard push back, but no one has yet provided a plausible explanation for how HIV glycoproteins naturally occurred in a coronavirus.
I posit that it is extremely unlikely to have naturally occurred within any timeline that makes sense, and is far more likely to have been inserted during a gain of function study.